Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-05

Clinical Trial Update: Safety of Rt-PA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated safety of combining alteplase (rt-PA) with transcranial emission of low-energy lasers for acute ischemic stroke. The study was terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Activase (alteplase)

Snippet

Sponsor: University of California, San Diego | Conditions: Ischemic Stroke | Phase 2 | Status: TERMINATED | Results posted: 2016-12-05